nuclear
first
identifi
bcell
transcript
factor
protein
bind
immunoglobulin
heavi
chain
kappa
light
chain
enhanc
sen
baltimor
known
compris
famili
ubiquit
protein
conserv
fruit
fli
drosophila
melanogast
human
control
express
gene
involv
plethora
function
immunoreceptor
express
express
chemokin
cytokin
cell
adhes
molecul
prolifer
transform
apoptosi
angiogenesi
oxid
stress
invas
metastasi
baeuerl
henkel
giuliani
et
al
kim
et
al
lee
burckart
extens
research
carri
last
year
understand
role
inflamm
cancer
order
design
strategi
block
excess
activ
articl
focus
signal
pathway
emphas
role
pulmonari
inflamm
cancer
modul
therapeut
agent
five
mammalian
famili
member
character
clone
rela
relb
crel
barkett
gilmor
dutta
et
al
ghosh
et
al
hayden
ghosh
jeong
et
al
mercurio
man
nabel
verma
pahl
shishodia
aggarw
famili
member
share
highli
conserv
amino
acid
rel
homolog
domain
rhd
respons
dimer
bind
dna
inhibitor
blank
et
al
chen
ghosh
gilmor
hayden
ghosh
perkin
gilmor
ntermin
part
rhd
contain
dnabind
domain
wherea
close
ctermin
end
rhd
lie
nuclear
local
sequenc
nl
essenti
transport
activ
complex
nucleu
protein
subdivid
two
group
rela
relb
crel
contain
potent
transactiv
domain
td
within
sequenc
ctermin
rhd
includ
first
group
wherea
possess
td
therefor
act
sole
transcript
activ
compris
second
group
td
consist
abund
serin
acid
hydrophob
amino
acid
essenti
transactiv
activ
mercurio
man
perkin
wang
baldwin
zhong
et
al
rhd
rel
protein
except
rel
b
contain
phosphoryl
site
pka
aa
ntermin
nl
phosphoryl
site
may
requir
nuclear
local
rel
protein
andor
may
involv
transcript
activ
dnabind
scheinman
et
al
wissink
et
al
zhong
et
al
local
cytoplasm
associ
inhibitori
protein
inact
form
famili
member
famili
deriv
ctermin
chicken
homolog
cactu
drosophila
homolog
avian
swine
fever
viru
protein
baldwin
barkett
gilmor
hatada
et
al
hayden
ghosh
balanc
local
depend
degrad
lead
exposur
mask
nl
also
reduc
contribut
nuclear
export
sequenc
arenzanaseisdedo
et
al
johnson
et
al
function
dimer
abund
activ
dimer
form
consist
subunit
subunit
howev
dimer
composit
depend
cell
type
natur
stimulu
lag
time
initi
exposur
stimuli
barkett
gilmor
hayden
ghosh
perkin
saccani
et
al
homo
heterodim
report
repress
sitedepend
transcript
vivo
lernbech
et
al
possibl
compet
transcript
activ
dimer
eg
dna
bind
interestingli
transcript
activ
demonstr
vitro
lin
et
al
signal
occur
classic
nonclass
pathway
classic
pathway
tumor
necrosi
factor
stimul
lead
activationphosphoryl
kinas
ikk
complex
phosphoryl
two
ntermin
serin
residu
protein
ikk
complex
compris
regulatori
subunit
essenti
modul
nemo
mercurio
et
al
rothwarf
et
al
yamaoka
et
al
form
homo
hetero
dimer
although
cooper
phosphoryl
kinas
differ
signal
mediat
amino
acid
homolog
similar
structur
organ
includ
kinas
domain
leucin
zipper
helixloophelix
domain
delhas
et
al
didonato
et
al
li
et
al
mercurio
et
al
regnier
et
al
woronicz
et
al
zandi
et
al
map
kinas
domain
protein
consist
close
space
serin
residu
posit
posit
phosphoryl
serin
residu
upstream
kinas
activ
ikk
kinas
didonato
et
al
vanden
bergh
et
al
zandi
et
al
signal
induc
activ
caus
phosphoryl
subsequ
lead
dissoci
degrad
therebi
allow
protein
enter
nucleu
induc
gene
express
fig
ubiquitin
subsequ
degrad
mediat
multicatalyt
atpdepend
proteasom
complex
evid
provid
experi
peptid
aldehyd
inhibitor
proteasom
eg
calpain
inhibitor
alln
karin
benneriah
besid
classic
pathway
altern
pathway
trigger
cytokin
lymphotoxin
bcell
activ
factor
ligand
virus
viru
tcell
leukemia
viru
pathway
nemo
independ
reli
recruit
tnf
receptor
associ
factor
traf
protein
membran
induc
kinas
nik
activ
homodim
whose
substrat
xiao
et
al
phosphoryl
undergo
ubiquitin
cleav
gener
protein
move
nucleu
heterodim
relb
fig
third
pathway
classifi
atyp
independ
ikk
still
requir
proteasom
trigger
dna
damag
kato
et
al
uv
radiat
induc
degrad
via
proteasom
target
serin
residu
locat
within
ctermin
cluster
recogn
activ
casein
kinas
fig
besid
also
target
phosphoryl
ikk
complex
trigger
degrad
ikk
phosphoryl
lead
ubiquitin
process
addit
glycogen
synthas
kinas
phosphoryl
prime
ikkmedi
phosphoryl
subsequ
degrad
fig
besid
classic
altern
pathway
activ
exposur
epitheli
surfac
lung
cigarett
smoke
lead
increas
nadph
oxidas
deriv
reactiv
oxygen
speci
ro
product
also
play
major
role
activ
via
nik
mekkpkcmedi
pathway
fig
variou
kinas
phosphoryl
cytoplasm
nucleu
stimuli
andor
cell
type
specif
protein
kinas
phosphoryl
degrad
essenti
recruit
crebbind
activ
transcript
mitogen
stressactiv
protein
also
phosphoryl
follow
tnf
stimul
vermeulen
et
al
addit
protein
kinas
phosphoryl
requir
recruit
crebbind
protein
rna
polymeras
ii
promot
duran
et
al
ikeda
et
al
mckay
cidlowski
shenkar
et
al
tabakinfix
et
al
phosphoryl
casein
kinas
ii
kinas
follow
tnf
lp
stimul
increas
transcript
activ
within
rhd
involv
dimer
wherea
ctermin
transactiv
domain
moreov
threonin
phosphoryl
residu
shown
requir
associ
increas
stabil
known
phosphoryl
mutual
exclus
whether
three
requir
activ
transcript
recent
studi
reveal
besid
phosphoryl
multitud
posttransl
modif
signal
system
includ
acetyl
nitrosyl
ubiquitin
neddyl
sumoyl
also
play
signific
role
regul
function
mabb
miyamoto
crystal
structur
heterodim
bound
reveal
lysin
residu
contact
dna
minor
groov
amongst
residu
involv
dna
bind
chen
ghosh
although
acetyl
lysin
residu
subunit
includ
also
play
signific
role
dnabind
capac
chen
et
al
transcript
regul
acetyl
within
shown
reduc
affin
kiernan
et
al
studi
propos
acetyl
protect
inhibit
howev
histon
deacetylas
mediat
deacetyl
render
prone
interact
lead
export
nucleu
glozak
seto
induc
methyl
demethyl
residu
respons
constitut
activ
chromatinremodel
enzym
report
earlier
lu
et
al
posttransl
modif
profoundli
affect
function
interestingli
lysin
residu
methyl
acetyl
depend
specif
cellular
context
way
lysin
methyl
acetyl
control
fine
regul
activ
normal
tumor
cell
mechan
control
time
locat
intens
residu
specif
type
modif
import
issu
futur
research
support
notion
differenti
posttransl
modif
occur
respons
differ
signal
phosphoryl
acetyl
methyl
report
may
specifi
differ
promoterspecif
respons
activ
perkin
lead
signalspecif
downstream
effect
respons
differ
regul
differ
cell
type
differ
specif
context
perkin
gilmor
demonstr
methyl
regul
transcript
activ
ea
baltimor
yang
et
al
methyl
local
nucleu
regul
stabil
complex
therebi
affect
recruit
promot
differ
vitro
find
differ
group
attribut
use
differ
epitop
tag
gener
recombin
fragment
activ
via
tolllik
receptor
mediat
signal
play
import
role
haemophilu
pneumonia
infect
lim
et
al
wherea
key
molecul
signal
shown
regul
activ
pulmonari
escherichia
coli
infect
cai
et
al
protect
mice
endogen
e
coli
alcamo
et
al
mizgerd
et
al
pneumococc
pneumonia
report
earlier
quinton
et
al
tirap
also
play
essenti
role
regul
e
coli
infect
jeyaseelan
et
al
similarli
trif
import
signal
essenti
late
activ
pulmonari
e
coli
jeyaseelan
et
al
pseudomona
aeruginosa
power
et
al
klbesiella
pneumonia
infect
cai
et
al
fig
lpsinduc
express
chemokin
kc
significantli
affect
defici
howev
express
chemokin
almost
entir
inhibit
combin
defici
rela
lpsinduc
increas
pulmonari
express
shown
reduc
defici
alon
promin
rela
combin
defici
jone
et
al
observ
reveal
rela
isoform
promot
coordin
express
cell
adhes
molecul
chemokin
essenti
neutrophil
immigr
respons
bacteri
lp
lung
sawa
et
al
et
al
vitro
studi
show
legionella
pneumophila
induc
degrad
activ
inhibit
ikk
block
l
pneumophilainduc
prostaglandin
e
releas
express
via
pathway
thu
significantli
contribut
host
respons
legionnair
diseas
n
guessan
et
al
studi
macrophag
compon
nadph
oxidas
complex
mice
confirm
redox
signal
necessari
maxim
activ
p
aeruginosa
infect
sadikot
et
al
vitro
experi
demonstr
activ
streptococcu
pneumonia
depend
mediat
protein
kinas
irak
receptor
activ
kinas
also
sens
intracellular
pneumonia
macrophag
upon
phagocytosi
induc
cytokin
product
via
pathway
opitz
et
al
recent
studi
combin
defici
signal
reduc
activ
chemokin
express
observ
pulmonari
infect
pneumonia
compar
e
coli
show
import
quinton
et
al
use
heatkil
staphylococcu
aureu
kapetanov
et
al
show
signal
import
cytokin
product
via
activ
fig
observ
reveal
extracellular
intracellular
pattern
recognit
receptor
regul
independ
pathway
trigger
varieti
pathogen
regard
cell
specif
respons
import
discuss
role
hematopoet
nonhematopoiet
cell
neutrophil
purifi
bone
marrow
cell
bone
marrowderiv
macrophag
bmm
gene
defici
mice
unabl
activ
signal
subsequ
pulmonari
infect
gram
neg
bacteria
shown
express
cell
type
import
neutrophilmedi
inflamm
regul
driven
lung
follow
lp
challeng
cai
et
al
bmm
modul
lung
inflamm
upon
k
pneumonia
infect
via
elrcxc
chemokin
kcmediat
activ
mapk
cai
et
al
addit
signal
hematopoet
nonhematopoiet
cell
essenti
control
p
aeruginosa
replic
initi
phase
infect
express
resid
cell
play
vital
role
chemokin
product
control
infect
wherea
earli
product
also
depend
signal
bone
marrow
cell
hajjar
et
al
anoth
studi
rela
defici
airway
epitheli
cell
result
observ
lead
decreas
cytokin
express
alveolar
neutrophil
influx
lung
bacteri
kill
pneumonia
infect
schmeck
et
al
furthermor
mice
express
dominantneg
form
airway
epitheli
cell
also
show
impair
bacteri
kill
lung
implic
import
activ
pneumonia
use
transgen
mice
express
mutat
exclus
airway
epitheli
cell
act
repressor
poynter
et
al
demonstr
role
airway
epitheli
cell
regul
secret
cytokineschemokin
intranas
administr
lp
koay
et
al
use
liposomeencapsul
clodron
deplet
macrophag
studi
role
macrophag
pathogenesi
neutrophil
lung
inflamm
respons
intraperiton
ip
lp
observ
studi
reveal
involv
pulmonari
extrapulmonari
macrophag
pool
control
lpsinduc
pulmonari
inflamm
intra
tracheal
administr
clodron
macrophag
deplet
result
reduc
activ
cytokineschemokin
product
express
togeth
find
conclus
reveal
import
signal
hematopoet
nonhematopoiet
cell
lentsch
et
al
comprehens
mechan
involv
activ
differ
bacteri
speci
shown
fig
tabl
cigarett
smoke
cs
potent
stimulu
inflamm
lung
contain
differ
compound
burn
bioactiv
lp
one
major
compon
cs
may
contribut
pathogenesi
hasday
et
al
cs
main
etiolog
factor
pathogenesi
chronic
obstruct
pulmonari
diseas
copd
caus
oxid
stress
key
featur
smoke
induc
lung
inflamm
cs
provok
sever
inflamm
result
product
cytokin
recruit
neutrophil
lung
lead
acut
lung
injuri
emphysema
churg
et
al
deng
et
al
macne
et
al
studi
also
shown
cs
induc
inflamm
lung
also
reduc
pulmonari
host
defenc
make
respiratori
system
prone
infect
smoker
incur
twofold
fourfold
increas
risk
invas
pneumococc
diseas
increas
risk
influenza
tuberculosi
infect
arcavi
benowitz
report
earlier
bacteri
burden
csexpos
mice
increas
h
postinfect
accompani
pronounc
clinic
appear
ill
hypothermia
increas
lung
homogen
cytokin
phipp
et
al
interestingli
anoth
group
found
cs
chang
bacteri
coloni
oral
caviti
gram
neg
bacilli
thu
potenti
chanc
aspir
pneumonia
caus
gram
neg
bacteria
ertel
et
al
use
oligodeoxynucleotid
longterm
csinduc
lung
inflamm
patholog
mice
shown
play
import
role
recruit
macrophag
pulmonari
dysfunct
smokeinduc
chronic
lung
inflamm
li
et
al
cs
extract
activ
upregul
bclxl
human
bronchial
epitheli
cell
defici
cell
lead
csmediat
cell
death
suggest
activ
regul
cell
surviv
follow
dna
damag
cs
liu
et
al
nadph
oxidasederiv
ro
product
upon
exposur
epitheli
surfac
lung
cs
also
play
major
role
activ
yao
et
al
fig
studi
shown
lp
p
aeruginosainduc
lung
activ
impair
knockout
mice
nadph
oxidas
member
protein
koay
et
al
sadikot
et
al
demonstr
activ
rela
subunit
decreas
lung
mice
compar
wildtyp
wt
mice
respons
cs
exposur
contrast
report
demonstr
nadph
defici
enhanc
lpsinduc
acut
inflammatori
respons
vivo
zhang
et
al
furthermor
low
ip
dose
lp
bodi
weight
bw
equal
induc
pulmonari
activ
wt
mice
howev
bw
ip
dose
lpsmediat
activ
lower
mice
koay
et
al
support
observ
anoth
report
show
suscept
cigarett
smokeinduc
lung
inflamm
emphysema
significantli
enhanc
mice
genet
ablat
nadph
oxidas
yao
et
al
contradictori
find
clearli
state
low
dose
lp
induc
activ
via
ro
mice
defici
nadph
oxidas
compon
compens
defect
either
xanthin
oxidas
faggioni
et
al
nakai
et
al
mitochondriamedi
ro
product
boczkowski
et
al
ritter
et
al
interestingli
variat
lp
dose
differ
observ
time
use
differ
anim
model
may
also
play
import
role
differenti
regul
key
player
regul
transcript
activ
histon
deacetylas
hdac
hdac
play
import
role
maintain
balanc
histon
acetylationdeacetyl
andor
transcript
activ
proinflammatori
gene
cell
remov
acetyl
group
lysin
residu
ntermin
end
core
histon
also
nonhiston
protein
csmediat
reduct
associ
increas
rela
activ
yao
et
al
also
observ
rela
interact
becom
avail
retain
nucleu
proinflammatori
gene
transcript
decreas
yang
et
al
therefor
understand
mechan
regul
could
provid
scope
therapeut
modul
steroid
resist
csinduc
lung
inflamm
cs
caus
immunosuppress
smoker
constitu
cs
toxic
cell
compon
break
innat
immun
barrier
respiratori
system
therebi
make
vulner
infect
compon
like
lp
stimul
innat
immun
cell
alveolar
macrophag
epitheli
cell
produc
proinflammatori
mediat
chemokin
cytokin
furthermor
constitut
cs
exposur
caus
progress
damag
innat
immun
barrier
therebi
stimul
inflamm
therefor
chronic
cs
exposur
make
viciou
cycl
go
reason
although
cs
immunosuppress
time
inflammatori
mehta
et
al
sopori
howev
investig
elucid
relat
molecular
mechan
still
warrant
lung
cancer
also
known
bronchogen
carcinoma
broadli
classifi
two
type
small
cell
lung
cancer
sclc
nonsmal
cell
lung
cancer
nsclc
sclc
compris
lung
cancer
aggress
rapidli
grow
lung
cancer
nsclc
common
lung
cancer
account
lung
cancer
meylan
et
al
immunohistochem
higher
express
nuclear
observ
sclc
compar
nsclc
tang
et
al
peroxisom
proliferatoractiv
agonist
induc
prolifer
nsclc
cell
inhibit
express
phosphat
tensin
homolog
delet
chromosom
pten
stimul
signal
han
et
al
tabl
target
signal
pathway
may
also
help
sensit
cancer
cell
tnfrelat
apoptosisinduc
ligand
trail
also
known
use
complementari
gene
therapi
modal
demonstr
combin
treatment
induc
signific
apoptosi
trailresist
cell
suggest
dual
gene
therapi
strategi
involv
exogen
trail
gene
express
concurr
ikk
inhibit
may
promis
gene
therapi
modal
treat
lung
cancer
aydin
et
al
environment
factor
tobacco
smoke
genet
suscept
interact
influenc
carcinogenesi
ga
phase
cs
contain
free
radic
superoxid
radic
hydroxyl
radic
hydrogen
peroxid
potenti
activ
shishodia
et
al
benzopyren
anoth
potent
carcinogen
cs
also
activ
unknown
mechan
shishodia
et
al
tabl
activ
play
import
role
lung
cancer
pathogenesi
suitabl
target
develop
new
lung
cancer
therapi
chemoprevent
strategi
meylan
et
al
shown
nuclear
rela
potenti
marker
nsclc
associ
poor
prognosi
addit
cs
induc
dna
damag
cell
cycl
arrest
without
lead
apoptosi
also
stimul
bind
activ
upregul
bclxl
liu
et
al
group
suggest
damag
dna
inhibit
apoptosi
cs
caus
epigenet
chang
andor
somat
cell
mutat
lead
lung
cancer
recurr
chronic
inflamm
may
induc
increas
suscept
tumorigenesi
damag
dna
elicit
repar
prolifer
creat
stromal
tissu
enrich
inflammatori
growth
signal
molecul
persist
inflamm
caus
constitut
stress
tissu
modifi
growth
signal
lead
metaplast
tissu
eventu
becom
neoplast
coussen
werb
chronic
inflamm
may
involv
unresolv
acut
inflamm
evolv
period
time
without
clinic
manifest
acut
inflamm
chronic
inflamm
character
cellular
influx
predominantli
macrophag
lymphocyt
multipl
permeabl
small
blood
vessel
fibrosi
necrosi
activ
macrophag
lymphocyt
produc
cytokin
chemokin
amplifi
inflammatori
signal
result
concurr
tissu
destruct
repair
balkwil
chemokin
compris
largest
famili
cytokin
lead
migrat
activ
leukocyt
site
infect
also
tumor
stroma
addit
chemokin
also
stimul
cell
caus
releas
proteolyt
enzym
help
digest
extracellular
matrix
alter
open
migratori
path
inflammatori
cell
therebi
lead
tumor
growth
metastasi
furthermor
increas
product
reactiv
oxygen
nitrogen
speci
cardin
featur
inflam
tissu
nitric
oxid
product
shown
caus
dna
mutat
inhibit
apoptosi
dna
protein
damag
induc
angiogenesi
alveolar
macrophag
neutrophil
lymphocyt
fibroblast
endotheli
cell
mediat
releas
cytokin
chemokin
growth
factor
may
act
promot
epitheli
dysfunct
malign
progress
epitheli
abnorm
induc
smoke
may
also
lead
abnorm
inflammatori
respons
initi
deregul
inflamm
role
chemokin
ligand
cxcl
yuan
et
al
human
nsclc
demonstr
earlier
white
et
al
vitro
vivo
express
regul
nsclc
anoth
report
demonstr
upregul
express
chemokin
activ
nuclear
transloc
led
enhanc
nsclc
tumor
growth
angiogenesi
vivo
pold
et
al
william
et
al
multipl
signal
pathway
includ
mapk
lead
regul
alter
level
lead
regul
cell
cycl
apoptosi
angiogenesi
interestingli
inhibit
block
expans
earli
alveolar
neoplast
lesion
wislez
et
al
cancer
complex
diseas
involv
divers
caus
development
stage
cell
target
etiolog
root
compound
degre
genom
instabl
cancer
cell
share
common
featur
overrid
normal
control
prolifer
homeostasi
certain
system
upregul
associ
advanc
stage
oncogenesi
support
role
tumor
progress
activ
express
gene
import
invas
metastasi
includ
angiogen
factor
like
vascular
endotheli
growth
factor
vegf
proteolyt
enzym
matrix
metalloproteinas
urokinas
plasminogen
activ
upa
kunsch
rosen
li
et
al
libermann
baltimor
novak
et
al
sovak
et
al
elev
circul
level
upa
upa
receptor
found
nsclc
patient
termin
diseas
hennek
et
al
veal
et
al
role
oncogenesi
first
propos
express
studi
antisens
transcript
transform
mous
cell
tumor
cell
beauparl
et
al
persist
nuclear
dna
bind
transactiv
activ
mani
human
tumor
clearli
reveal
defect
activ
simultan
invers
correl
level
oncogenesi
report
group
result
consist
report
show
activ
ikk
lead
destruct
factor
devalaraja
et
al
newton
et
al
thu
studi
propos
act
tumor
suppressor
control
oncogen
activ
studi
report
reduc
cancer
risk
patient
antiinflammatori
drug
caus
role
proteolyt
enzym
transcript
factor
cytokin
tnf
potenti
inflammationbas
cancer
extens
support
relationship
coussen
werb
greten
et
al
pikarski
et
al
switch
nontransform
cancer
cell
epigenet
respons
transient
inflammatori
signal
via
posit
feedback
loop
involv
directli
activ
inhibit
pten
cyld
tumor
suppressor
lead
increas
activ
requir
maintain
transform
state
regulatori
circuit
requir
transform
state
divers
cell
line
tumor
growth
xenograft
transcript
signatur
observ
colon
adenocarcinoma
thu
epigenet
switch
involv
pten
cyld
part
posit
feedback
loop
underli
epigenet
switch
link
inflamm
cancer
via
iliopoulo
et
al
pulmonari
diseas
greatest
risk
lung
cancer
associ
copd
tobacco
smoke
consid
major
caus
copd
tobacco
smoke
provid
persist
network
inflammatori
stimuli
copd
give
environ
transit
cancer
progress
engel
sasco
et
al
smith
et
al
eventu
lead
loss
host
immun
function
infect
tumor
format
mechan
inflamm
affect
apoptosi
center
around
activ
divers
stimuli
includ
proinflammatori
cytokin
infecti
agent
cellular
stress
wang
cho
therefor
signal
pathway
also
provid
focu
pharmacolog
intervent
cancer
pathway
often
constitut
activ
play
key
role
diseas
concomitantli
inhibit
pharmacolog
molecular
mean
sensit
cancer
cell
activ
chemic
induc
oxid
stress
death
meng
et
al
inhibitor
pathway
identifi
includ
varieti
natur
synthet
molecul
compound
includ
antioxid
peptid
small
rnadna
microbi
viral
protein
small
molecul
engin
dominantneg
constitut
activ
polypeptid
gilmor
herscovitch
tabl
sever
molecul
act
gener
inhibitor
induct
wherea
other
inhibit
specif
pathway
induct
pathway
target
inhibit
proteasom
function
prevent
degrad
degradationresist
protein
glucocorticoidmedi
repress
pathway
nonsteroid
antiinflammatori
drug
immunosuppress
agent
cyclopentenon
prostaglandin
natur
product
flavonoid
also
inhibit
pathway
yamamoto
gaynor
bortezomibvelcad
highli
specif
inhibitor
proteasom
current
approv
treatment
multipl
myeloma
richardson
et
al
similarli
disulfiram
olmesartan
dithiocarbam
also
inhibit
signal
cascad
similar
manner
cvek
dvorak
bortezomib
dipeptidyl
boron
acid
select
specif
inhibit
proteasom
inhibit
proteasom
bortezomib
reduc
activ
bclxl
level
therebi
lead
growth
arrest
cancer
cell
impair
angiogenesi
decreas
metastasi
increas
suscept
chemotherapi
tabl
first
food
drug
administr
fda
approv
proteasom
inhibitor
evalu
frontlin
second
line
therapi
nsclc
sclc
bortezomib
monotherapi
combin
cytotox
drug
shown
promis
result
bortezomib
although
fda
approv
drug
multipl
myeloma
efficaci
differ
cancer
mantl
cell
follicular
nonhodgkin
lymphoma
peripher
tcell
lymphoma
macroglobulinemia
chronic
lymphocyt
leukemia
prostat
cancer
ovarian
cancer
still
evalu
nevertheless
combin
drug
bortezomib
show
degre
activ
keep
toxic
manag
rang
date
least
clinic
trial
use
bortezomib
alon
combin
regist
us
sourc
clinicaltrialsgov
databas
access
feb
almost
resist
cancer
includ
solid
tumor
melanoma
malign
glioma
kidney
colon
breast
lung
pancrea
head
neck
cancer
well
hematolog
malign
studi
phase
ii
particularli
look
use
lung
cancer
mainli
nsclc
variou
stage
treatment
condit
decid
dose
toler
addit
efficaci
bortezomib
also
evalu
cotreat
chemotherapi
docetaxel
cetuximab
lilenbaum
et
al
pemetrex
scagliotti
et
al
carboplatin
paclitaxel
radiotherapi
edelman
et
al
gemcitabin
cisplatin
voortman
et
al
docetaxel
lara
et
al
studi
use
bortezomib
plu
gemcitabinecarboplatin
result
notabl
surviv
benefit
patient
advanc
nsclc
phase
davi
et
al
phase
ii
trial
davi
et
al
nonsteroid
antiinflammatori
drug
glucocorticoid
shown
activ
differ
cancer
model
induct
apoptosi
growth
arrest
possibl
due
inhibit
yamamoto
gaynor
cyclosporin
tacrolimu
immunosuppress
agent
use
organ
transplant
prevent
graftversushost
diseas
agent
prevent
activ
specif
condit
inhibit
activ
calcineurin
calcium
calmodulindepend
serinethreonin
phosphatas
frantz
et
al
meyer
et
al
venkataraman
et
al
proteasom
inhibitor
peptid
aldehyd
includ
make
class
agent
inhibit
proteas
activ
proteasom
class
includ
lactacystin
block
protein
degrad
activ
acyl
threonin
residu
one
key
proteasom
subunit
natur
compound
like
edibl
plantderiv
flavonoid
exhibit
varieti
biolog
activ
includ
suppress
inflamm
cancer
chemoprevent
protect
vascular
diseas
report
suggest
properti
flavonoid
quercetin
resveratrol
myricetin
fisetin
apigenin
may
mediat
downregul
pathway
holmesmcnari
baldwin
tsai
et
al
thiocolchicosid
semisynthet
colchicosid
plant
gloriosa
superba
inhibit
prolifer
leukemia
myeloma
squamou
cell
carcinoma
breast
colon
kidney
cancer
cell
induc
apoptosi
suppress
format
tumor
coloni
inhibit
gene
product
reuter
et
al
one
extens
studi
compound
group
curcumin
diferuloylmethan
deriv
turmer
shown
suppress
activ
gene
express
anto
et
al
mukhopadhyay
et
al
shishodia
et
al
nimbolid
triterpenoid
isol
azadirachta
indica
enhanc
apoptosi
induc
inflammatori
cytokin
chemotherapeut
agent
tumor
cell
limonoid
abrog
express
protein
associ
cell
surviv
bclxl
prolifer
cyclin
invas
angiogenesi
vegf
inhibit
activ
induc
carcinogen
inflammatori
stimuli
gupta
et
al
natur
occur
isothiocyan
allyl
isothiocyan
benzyl
isothiocyan
bitc
phenethyl
isothiocyan
sulphoraphan
shown
offer
protect
chemic
induc
cancer
experiment
anim
conaway
et
al
fimognari
hrelia
hecht
bitc
treatment
led
decreas
transcript
activ
bind
bitctreat
pancreat
cancer
cell
line
cell
decreas
phosphoryl
concomit
reduc
hdac
activ
cyclin
express
batra
et
al
agent
interfer
dimer
famili
member
also
possibl
therapeut
target
near
futur
gilmor
herscovitch
vitro
use
transdomin
mutant
line
alreadi
report
howev
studi
area
intervent
still
warrant
logeat
et
al
furthermor
compound
target
specif
posttransl
modif
provid
exquisit
specif
regul
transactiv
relat
specif
gene
compound
shown
specif
block
phosphoryl
includ
mesuol
marquez
et
al
pertussi
iordanskiy
et
al
mesalamin
egan
et
al
anoth
challeng
aspect
regard
therapeut
intervent
identifi
moleculescompound
inhibit
distinct
complex
variou
experiment
modelscel
type
upon
specif
stimul
preliminari
effort
respect
made
choi
et
al
isomura
morita
use
antisens
oligonucleotid
rel
sinc
rela
common
subunit
system
effect
approach
variou
diseas
condit
clear
need
studi
altern
low
dose
multi
drug
combin
use
inhibitor
approach
seem
promis
may
target
multipl
step
pathway
reduc
side
effect
one
exampl
context
thiol
reactiv
compound
target
upstream
kinas
ikk
well
dna
bind
transcript
factor
keep
view
pharmacolog
natur
compound
target
show
encourag
result
variou
carcinoma
quit
like
effect
measur
degre
lung
cancer
inspit
sever
advanc
saga
futur
progress
certainli
direct
resolv
mysteri
relat
regul
signal
pathway
patholog
diseas
therapeut
potenti
use
variou
model
system
inspit
abund
literatur
avail
regard
signal
pathway
associ
scant
inform
avail
regard
role
variou
dimer
form
famili
member
differ
condit
expect
see
report
understudi
area
recent
year
anoth
area
futur
investig
would
explor
possibl
applic
inhibitor
topic
local
use
eg
skin
inflamm
airway
inflamm
respect
intervent
extern
agent
regul
posttransl
modif
anoth
area
scantili
explor
numer
report
discuss
regul
respons
infect
variou
pathogen
recent
advanc
use
condit
knockout
mice
may
reveal
interest
novel
role
famili
member
besid
complex
understand
signal
pathway
still
remain
focu
therapeut
intervent
variou
diseas
condit
includ
pulmonari
infect
cancer
furthermor
futur
may
expect
see
studi
use
combin
therapi
may
prove
effect
benefici
target
multipl
step
low
dose
transcript
factor
link
sever
metabol
inflammatori
diseas
includ
variou
type
cancer
increas
understand
regul
inflamm
chronic
diseas
also
shown
involv
resist
multipl
drug
therapi
variou
degre
activ
induct
epigenet
switch
promot
free
radic
gener
cellular
stress
respons
mainten
antagon
tumor
suppressor
gene
product
apoptosi
specif
case
lung
cancer
induc
inflamm
due
habitu
environment
caus
like
cigarett
smoke
pertin
regulatori
hub
manipul
better
diseas
manag
major
therapeut
challeng
cancer
therapi
determin
molecul
destroy
cancer
cell
caus
minim
harm
somat
cell
regulatori
molecul
almost
cell
studi
done
cell
cultur
anim
model
usual
explain
human
system
extrem
difficult
pass
preclin
studi
therefor
better
understand
regul
posttransl
modif
dimer
particular
inflamm
lung
cancer
import
defin
promis
pharmacolog
natur
inhibitor
treatmentmanag
diseas
